Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-R Burmester

Showing results (131-140 of 293) with videos related to

Pageof 30
Sort By:
Arthritis Research & Therapy|September 10, 2020
Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trialsMark C Genovese, Gerd R Burmester, Owen Hagino, et al.
Clinical Rheumatology|March 20, 2008
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody statusArie E van der Bijl, Ferdinand C Breedveld, Christian E Antoni, et al.
BMC Rheumatology|May 22, 2024
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritisJeffrey A Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, et al.
RMD Open|January 4, 2023
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-upMichaela Koehm, Sarah Ohrndorf, Ann C Foldenauer, et al.
Arthritis and Rheumatism|June 3, 2008
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95Annett M Jacobi, Karin Reiter, Meggan Mackay, et al.
The American Journal of Pathology|August 26, 2003
Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissueBruno Stuhlmüller, Elke Kunisch, Juliane Franz, et al.
Annals of the Rheumatic Diseases|March 3, 2007
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trialGerd R Burmester, Xavier Mariette, Carlomaurizio Montecucco, et al.
Annals of the Rheumatic Diseases|October 28, 2021
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated databasePeter C Taylor, Tsutomu Takeuchi, Gerd R Burmester, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 24, 2018
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid ArthritisGerd R Burmester, Iain B McInnes, Joel M Kremer, et al.
Annals of the Rheumatic Diseases|December 21, 2012
The role of biosimilars in the treatment of rheumatic diseasesThomas Dörner, Vibeke Strand, Gilberto Castañeda-Hernández, et al.
Pageof 30

Showing results (131-140 of 293) with videos related to

Sort By:
Pageof 30
Arthritis Research & Therapy|September 10, 2020
Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trialsMark C Genovese, Gerd R Burmester, Owen Hagino, et al.
Clinical Rheumatology|March 20, 2008
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody statusArie E van der Bijl, Ferdinand C Breedveld, Christian E Antoni, et al.
BMC Rheumatology|May 22, 2024
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritisJeffrey A Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, et al.
RMD Open|January 4, 2023
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-upMichaela Koehm, Sarah Ohrndorf, Ann C Foldenauer, et al.
Arthritis and Rheumatism|June 3, 2008
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95Annett M Jacobi, Karin Reiter, Meggan Mackay, et al.
The American Journal of Pathology|August 26, 2003
Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissueBruno Stuhlmüller, Elke Kunisch, Juliane Franz, et al.
Annals of the Rheumatic Diseases|March 3, 2007
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trialGerd R Burmester, Xavier Mariette, Carlomaurizio Montecucco, et al.
Annals of the Rheumatic Diseases|October 28, 2021
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated databasePeter C Taylor, Tsutomu Takeuchi, Gerd R Burmester, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 24, 2018
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid ArthritisGerd R Burmester, Iain B McInnes, Joel M Kremer, et al.
Annals of the Rheumatic Diseases|December 21, 2012
The role of biosimilars in the treatment of rheumatic diseasesThomas Dörner, Vibeke Strand, Gilberto Castañeda-Hernández, et al.
Pageof 30